KEGG   Canis lupus familiaris (dog): 612821
Entry
612821            CDS       T01007                                 
Symbol
MAPK13
Name
(RefSeq) mitogen-activated protein kinase 13
  KO
K04441  p38 MAP kinase [EC:2.7.11.24]
Organism
cfa  Canis lupus familiaris (dog)
Pathway
cfa01522  Endocrine resistance
cfa04010  MAPK signaling pathway
cfa04015  Rap1 signaling pathway
cfa04068  FoxO signaling pathway
cfa04071  Sphingolipid signaling pathway
cfa04114  Oocyte meiosis
cfa04148  Efferocytosis
cfa04218  Cellular senescence
cfa04261  Adrenergic signaling in cardiomyocytes
cfa04370  VEGF signaling pathway
cfa04380  Osteoclast differentiation
cfa04550  Signaling pathways regulating pluripotency of stem cells
cfa04611  Platelet activation
cfa04613  Neutrophil extracellular trap formation
cfa04620  Toll-like receptor signaling pathway
cfa04621  NOD-like receptor signaling pathway
cfa04622  RIG-I-like receptor signaling pathway
cfa04625  C-type lectin receptor signaling pathway
cfa04657  IL-17 signaling pathway
cfa04658  Th1 and Th2 cell differentiation
cfa04659  Th17 cell differentiation
cfa04660  T cell receptor signaling pathway
cfa04664  Fc epsilon RI signaling pathway
cfa04668  TNF signaling pathway
cfa04670  Leukocyte transendothelial migration
cfa04714  Thermogenesis
cfa04722  Neurotrophin signaling pathway
cfa04723  Retrograde endocannabinoid signaling
cfa04728  Dopaminergic synapse
cfa04750  Inflammatory mediator regulation of TRP channels
cfa04912  GnRH signaling pathway
cfa04914  Progesterone-mediated oocyte maturation
cfa04917  Prolactin signaling pathway
cfa04926  Relaxin signaling pathway
cfa04932  Non-alcoholic fatty liver disease
cfa04933  AGE-RAGE signaling pathway in diabetic complications
cfa04935  Growth hormone synthesis, secretion and action
cfa04936  Alcoholic liver disease
cfa05014  Amyotrophic lateral sclerosis
cfa05020  Prion disease
cfa05022  Pathways of neurodegeneration - multiple diseases
cfa05132  Salmonella infection
cfa05133  Pertussis
cfa05135  Yersinia infection
cfa05140  Leishmaniasis
cfa05142  Chagas disease
cfa05145  Toxoplasmosis
cfa05152  Tuberculosis
cfa05161  Hepatitis B
cfa05163  Human cytomegalovirus infection
cfa05167  Kaposi sarcoma-associated herpesvirus infection
cfa05169  Epstein-Barr virus infection
cfa05170  Human immunodeficiency virus 1 infection
cfa05171  Coronavirus disease - COVID-19
cfa05205  Proteoglycans in cancer
cfa05208  Chemical carcinogenesis - reactive oxygen species
cfa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
cfa05415  Diabetic cardiomyopathy
cfa05417  Lipid and atherosclerosis
cfa05418  Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:cfa00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    612821 (MAPK13)
   04015 Rap1 signaling pathway
    612821 (MAPK13)
   04370 VEGF signaling pathway
    612821 (MAPK13)
   04668 TNF signaling pathway
    612821 (MAPK13)
   04068 FoxO signaling pathway
    612821 (MAPK13)
   04071 Sphingolipid signaling pathway
    612821 (MAPK13)
 09140 Cellular Processes
  09141 Transport and catabolism
   04148 Efferocytosis
    612821 (MAPK13)
  09143 Cell growth and death
   04114 Oocyte meiosis
    612821 (MAPK13)
   04218 Cellular senescence
    612821 (MAPK13)
  09144 Cellular community - eukaryotes
   04550 Signaling pathways regulating pluripotency of stem cells
    612821 (MAPK13)
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    612821 (MAPK13)
   04613 Neutrophil extracellular trap formation
    612821 (MAPK13)
   04620 Toll-like receptor signaling pathway
    612821 (MAPK13)
   04621 NOD-like receptor signaling pathway
    612821 (MAPK13)
   04622 RIG-I-like receptor signaling pathway
    612821 (MAPK13)
   04625 C-type lectin receptor signaling pathway
    612821 (MAPK13)
   04660 T cell receptor signaling pathway
    612821 (MAPK13)
   04658 Th1 and Th2 cell differentiation
    612821 (MAPK13)
   04659 Th17 cell differentiation
    612821 (MAPK13)
   04657 IL-17 signaling pathway
    612821 (MAPK13)
   04664 Fc epsilon RI signaling pathway
    612821 (MAPK13)
   04670 Leukocyte transendothelial migration
    612821 (MAPK13)
  09152 Endocrine system
   04912 GnRH signaling pathway
    612821 (MAPK13)
   04914 Progesterone-mediated oocyte maturation
    612821 (MAPK13)
   04917 Prolactin signaling pathway
    612821 (MAPK13)
   04926 Relaxin signaling pathway
    612821 (MAPK13)
   04935 Growth hormone synthesis, secretion and action
    612821 (MAPK13)
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    612821 (MAPK13)
  09156 Nervous system
   04728 Dopaminergic synapse
    612821 (MAPK13)
   04723 Retrograde endocannabinoid signaling
    612821 (MAPK13)
   04722 Neurotrophin signaling pathway
    612821 (MAPK13)
  09157 Sensory system
   04750 Inflammatory mediator regulation of TRP channels
    612821 (MAPK13)
  09158 Development and regeneration
   04380 Osteoclast differentiation
    612821 (MAPK13)
  09159 Environmental adaptation
   04714 Thermogenesis
    612821 (MAPK13)
 09160 Human Diseases
  09161 Cancer: overview
   05205 Proteoglycans in cancer
    612821 (MAPK13)
   05208 Chemical carcinogenesis - reactive oxygen species
    612821 (MAPK13)
   05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
    612821 (MAPK13)
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    612821 (MAPK13)
   05161 Hepatitis B
    612821 (MAPK13)
   05171 Coronavirus disease - COVID-19
    612821 (MAPK13)
   05163 Human cytomegalovirus infection
    612821 (MAPK13)
   05167 Kaposi sarcoma-associated herpesvirus infection
    612821 (MAPK13)
   05169 Epstein-Barr virus infection
    612821 (MAPK13)
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    612821 (MAPK13)
   05135 Yersinia infection
    612821 (MAPK13)
   05133 Pertussis
    612821 (MAPK13)
   05152 Tuberculosis
    612821 (MAPK13)
  09174 Infectious disease: parasitic
   05145 Toxoplasmosis
    612821 (MAPK13)
   05140 Leishmaniasis
    612821 (MAPK13)
   05142 Chagas disease
    612821 (MAPK13)
  09164 Neurodegenerative disease
   05014 Amyotrophic lateral sclerosis
    612821 (MAPK13)
   05020 Prion disease
    612821 (MAPK13)
   05022 Pathways of neurodegeneration - multiple diseases
    612821 (MAPK13)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    612821 (MAPK13)
   05418 Fluid shear stress and atherosclerosis
    612821 (MAPK13)
   05415 Diabetic cardiomyopathy
    612821 (MAPK13)
  09167 Endocrine and metabolic disease
   04936 Alcoholic liver disease
    612821 (MAPK13)
   04932 Non-alcoholic fatty liver disease
    612821 (MAPK13)
   04933 AGE-RAGE signaling pathway in diabetic complications
    612821 (MAPK13)
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    612821 (MAPK13)
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01001 Protein kinases [BR:cfa01001]
    612821 (MAPK13)
Enzymes [BR:cfa01000]
 2. Transferases
  2.7  Transferring phosphorus-containing groups
   2.7.11  Protein-serine/threonine kinases
    2.7.11.24  mitogen-activated protein kinase
     612821 (MAPK13)
Protein kinases [BR:cfa01001]
 Serine/threonine kinases: CMGC group
  MAPK family [OT]
   612821 (MAPK13)
SSDB
Motif
Pfam: Pkinase PK_Tyr_Ser-Thr ABC1 RIO1 APH Kdo Kinase-like
Other DBs
NCBI-GeneID: 612821
NCBI-ProteinID: XP_005627323
Ensembl: ENSCAFG00000001382
VGNC: 42994
UniProt: A0A8C0T102 A0A8I3NKJ3
LinkDB
Position
12:5259690..5268114
AA seq 366 aa
MSFTRKKGFYRQDVNKTAWELPKTYVSPTHVGSGAYGAVCCAIDKRSGEKVAIKKLSRPF
QSEIFAKRAYRELQLLKHMQHENVIGLLDVFTPASSLRSFHDFYLVMPFMQTDLQKIMGM
EFSEDKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT
GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLSQILKVTG
VPGAEFVQKLNDKAAKSYIQALPQSPKKDFSQLFPCASPQATDLLEKMLELDVDKRLTAS
QALAHPFFEPFRDPEEETEASQPFNDSLEHEKLTVDEWKQHIYKEIVNFSPIARKDSRRR
SGMKLQ
NT seq 1101 nt   +upstreamnt  +downstreamnt
atgagcttcacccggaaaaagggcttctacaggcaggacgtcaacaagaccgcctgggag
ctgcccaagacctacgtgtcgccgacgcacgtgggcagcggggcctacggcgcagtgtgc
tgtgccatcgacaagcggtcaggggagaaggtggccatcaagaagctgagccggcccttc
cagtctgagatctttgccaaacgtgcctaccgagagctgcagctgctgaagcacatgcag
catgaaaacgtcatcgggctcctggatgtcttcaccccagcctcctccctgcgcagcttc
catgacttctacctggtgatgcccttcatgcagacagacctgcagaagatcatggggatg
gagttcagtgaagacaagatccagtacctggtgtatcagatgctcaagggtctcaagtac
atccactcagctggggtcgtccacagggacctgaagccgggcaacctggccgtgaacgag
gactgcgagctgaagatcttggattttgggctggcccggcatgcggatgctgaaatgacc
ggctatgtggtgacccgctggtaccgggcccccgaggtgatcctcagctggatgcactac
aaccagactgtggacatctggtctgtgggctgcatcatggcagagatgctgacagggaaa
actctgttcaaggggaaagattacctggaccagctgtcccagatcctcaaagtgaccggg
gtcccgggtgcagaatttgtgcagaagttgaacgacaaagcagccaaatcctatatccag
gccctgccacagagccccaagaaggatttttctcagctcttcccgtgcgccagcccccag
gctacagacctgctggagaagatgctggagctggacgtggacaagcgcctgacggcctcg
caggccctcgcccaccctttctttgaacccttccgagaccctgaggaggagacagaggcc
tcgcagccctttaatgattccttagaacatgagaaactcacggtggatgaatggaagcag
cacatctacaaggagatcgtgaacttcagccccattgcccggaaggactcacggcgccgg
agcggcatgaagctgcagtga

DBGET integrated database retrieval system